Know AML spotlight: The KOMET-017 clinical trial

This educational resource is independently supported by Kura Oncology. All content was developed by SES in collaboration with an expert ambassador group. Funders were allowed no influence on the content of this resource.

Download

Share to LinkedIn

Share to X

Share to Facebook

All content on Know AML is primarily intended for patients and caregivers. If you are a healthcare professional, please visit the AML Hub.

Please get in touch if you have any questions about Know AML or if you would like to discuss a potential collaboration.

Brought to you by

Scientific Education Support

In collaboration with

Thank you to the funders of Know AML. All content is developed independently by SES in collaboration with an expert ambassador group; funders are allowed no influence on the content of Know AML.